Teladoc Health Inc

Teladoc Health Inc(TDOC)股票分析

$5.810

-0.184 (-3.17%)收盤時

Loading chart…
最高
5.960
開盤
5.810
成交量加權均價
5.83
成交量
3.52M
市值
1.72B
最低
5.710
成交金額
20.53M
企業價值/稅息折舊攤銷前利潤(TTM)
5.76

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

AI 分析 of Teladoc Health Inc (TDOC)

持有

Teladoc Health Inc is not a good buy right now due to its current price of $5.77 being significantly below analyst targets, with a forward P/E of 303.03 indicating high valuation expectations despite recent financial struggles. The main risk is the declining revenue from its BetterHelp service, which dropped by 12% year-over-year, suggesting ongoing competitive pressures.

分析師評級(13)

上檔空間 +53.36%
買進
10 買進
3 持有
0 賣出
目前: 5.81
最低
7.50
平均
8.91
最高
12.00

Citi

2026-08-03

目標價

$11

持有

Jefferies

2026-07-30

目標價

$8

持有

Evercore ISI

2026-07-30

目標價

$10

持有

Citi

2026-07-23

目標價

$11

中性

Canaccord

2026-07-21

目標價

$11

買進

估值指標

Teladoc Health Inc(TDOC)目前預期本益比為 303.03,5 年平均預期本益比為 31.88。

預期本益比

嚴重高估
5 年均值 P/E
31.88
目前P/E
303.03
高估
151.48
低估
-87.71

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
15.20
目前EV/EBITDA
5.76
高估
29.77
低估
0.63

預期股價營收比

合理
5 年均值 P/S
1.54
目前P/S
0.46
高估
3.28
低估
-0.19

Alphio AI 對 TDOC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%TDOC

$7.29

情境價格

基

基準

基準 · 50%TDOC

$6.49

情境價格

悲

悲觀

悲觀 · 25%TDOC

$6.11

情境價格

持有 TDOC 的大戶

P

Pale Fire Capital SE

+ 持有TDOC

-1.78%

3個月報酬率

V

Voss Capital, LP

+ 持有TDOC

-8.34%

3個月報酬率

事件時間軸

2026-09-25 (ET)

09:00:00

Teladoc Health Announces Legal Executive Transition

2026-08-31 (ET)

08:30:00

Teladoc Appoints Michael Grasher as CFO

2026-08-26 (ET)

10:30:00

Canada Raises Tariffs on U.S. Steel and Aluminum to 50%

2026-07-30 (ET)

17:00:00

Microsoft's Strong Earnings Boost Market Recovery

資訊

TDOC 常見問題 —— 由 Alphio AI 解答

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Teladoc Health Inc is not a good buy right now due to its current price of $5.77 being significantly below analyst targets, with a forward P/E of 303.03 indicating high valuation expectations despite recent financial struggles. The main risk is the declining revenue from its BetterHelp service, which dropped by 12% year-over-year, suggesting ongoing competitive pressures.

13 analysts cover TDOC: 10 rate it Buy, 3 Hold and 0 Sell. The average price target is 8.91.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易